RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @GulagMember0515: @FredMa7153 @Bms563 @RupaliChadhaMD Natural infection provides 95-95.2% efficacy. Natural immunity studies: https://t.…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@FredMa7153 @Bms563 @RupaliChadhaMD Natural infection provides 95-95.2% efficacy. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0W0RLYl2sx
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @GulagMember0515: @JeffyIsFat @ElijahSchaffer @CBroussely Incorrect. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIct…
RT @Abingdon_Health: The study concluded that the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substant…
RT @Abingdon_Health: The study concluded that the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substant…
#ODX immunity passes ???
The study concluded that the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months. 2/2 https://t.co/MBwbZsqlsh
Study measured anti-spike IgG measured of 12,541 health care workers. Results show there were no symptomatic infections in workers with anti-spike #antibodies. 1/2 https://t.co/KSPYH1QSLp
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@karenyo79605422 @dontbetyet @BettyJa08291909 But this is about immunity in people who were never exposed to the virus - they'll have those immunity for life! Not to mention the people who have had the virus who are also have a robust immune response which
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@lyndafarren @TBuk240 @chrischirp I think there have been a few studies, especially in HCWs. This one says substantially reduced risk for up to 6 months https://t.co/T5oWXST1G3
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @ifihadastick: If the risk of re-infection posed a public health threat, they would have the ability to ascertain rate of re-infections…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
If the risk of re-infection posed a public health threat, they would have the ability to ascertain rate of re-infections in our state. This corroborates with the research that shows re-infection both rare AND mild. https://t.co/aYQVzIkxdt https://t.co/eZ
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@DLaVa84 @pnjaban @Rachel__Bush Yes, it has. Natural immunity provides protection for at least 6 months with a 95-95-2 % efficacy. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim h
@Mom2C @dockaurG Natural immunity studies for Covid19: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0W0RLYl2sx https://t.co/beWYpBc7Lv https://t.co/VZFinYjHWT https://
@anubhabhonsle That's too bad, Evidence is very clear that antibodies persists at least 6 - 8 months. - https://t.co/slbxwWW3uW -https://t.co/QSl4o2W0Lr That too only because these studies were conducted only for that period, we'll likely see long-term
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @GulagMember0515: @kdbreedlove @MichaelPSenger 1) Vaccine passes ignore those who have acquired natural immunity. Natural immunity studi…
@kdbreedlove @MichaelPSenger 1) Vaccine passes ignore those who have acquired natural immunity. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @heavyinfo: @sumanthraman These - 'Lasting immunity found after recovery from COVID-19' - https://t.co/QSl4o2W0Lr 'Antibody Status and…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@kohvazein @MatHeller1 @jordanbpeterson Natural immunity studies regarding COVID19: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0W0RLYl2sx https://t.co/beWYpBc7Lv http
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @ZKForTre: @gerdosi @magnusnordborg Also, look at figure 2 of your cited power, please. Meanwhile. https://t.co/0tlMH8wJm0 https://t.…
RT @boticariors: 👉Duración inmunidad: sabemos que los que han padecido la enfermedad disponen en mayor o menor medida de una inmunidad prot…
@gerdosi @magnusnordborg Also, look at figure 2 of your cited power, please. Meanwhile. https://t.co/0tlMH8wJm0 https://t.co/DOvvWhqtuf https://t.co/2KdHcU4QfS https://t.co/IUiY8sBjny https://t.co/N3Qmx2WohJ Also this: https://t.co/rN2gjHCTyQ
@RozzWilliams1 @LindaMccarrel @amyklobuchar I form my own opinions. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0W0RLYl2sx https://t.co/beWYp
👉Duración inmunidad: sabemos que los que han padecido la enfermedad disponen en mayor o menor medida de una inmunidad protectora, pero lo que desconocemos es cuál será su duración. Aunque muchos datos apuntan a que será muy prolongada 38/n https://t.co/DM7
@TheRahulMehra That day is already here if one has recovered from COVID. Immunity dips only slightly even after 8 months - https://t.co/QSl4o2W0Lr, https://t.co/slbxwWW3uW On par with 6 months antibody of mRNA-1273 vaccine - https://t.co/jxE8WsaM0a Vu
@Neurophysik @Smita_Sharma There's overwhelming scientific evidence to suggest immunity from COVID disease lasts at least 8 months - https://t.co/QSl4o2W0Lr Natural immunity provided excellent protection against symptomatic COVID in the 6 month study of 1
@CKSWEN1 @__udontknow @Mel61502591 @amyklobuchar Incorrect. It's at least six months. Natural immunity studies: https://t.co/pyvj4uJm4t https://t.co/mIctE8kfP3 https://t.co/kDZx0NqOPv https://t.co/k3OE67Oxim https://t.co/jOctpHG5mA https://t.co/0W0RLYl2sx
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
@sumanthraman These - 'Lasting immunity found after recovery from COVID-19' - https://t.co/QSl4o2W0Lr 'Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers' - https://t.co/slbxwWW3uW This recommendation was long overdue, hope Gov
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…